PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria. aeolagunju@oauife.edu.ng.\', \'Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom. aeolagunju@oauife.edu.ng.\', \'Department of Medical Microbiology and Parasitology, College of Medicine, University of Ibadan, Ibadan, Nigeria.\', \'State Specialist Hospital, Osogbo, Nigeria.\', \'Department of Community Health, Faculty of Clinical Sciences, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria.\', \'Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria.\', \'Department of Epidemiology and Medical Statistics, Faculty of Public Health, University of Ibadan, Ibadan, Nigeria.\', \'Department of Community Medicine, University of Ibadan, Ibadan, Nigeria.\', \'Department of Surveillance and Epidemiology, Nigeria Centre for Disease Control, Abuja, Nigeria.\', \'Oyo State Ministry of Health, Ibadan, Nigeria.\', \'Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.\', \'African Centre of Excellence for Genomics of Infectious Diseases, Redeemer\'s University, Ede, Nigeria.\', \'Department of Chemistry, School of Physical Sciences, University of Liverpool, Liverpool, United Kingdom.\', \'Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04987-8
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33397457
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33397457>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33397457>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all